Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis

Direk Limmathurotsakul1, Nick Golding2, David Ab Dance3

  • 1Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, United Kingdom ; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand ; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.

Nature Microbiology
|February 16, 2016
PubMed

Insights

Melioidosis, caused by Burkholderia pseudomallei, is a serious global health threat. This study estimates 165,000 annual human cases and 89,000 deaths, highlighting significant underreporting and the need for public health action.

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Epidemiology

Background:

  • Melioidosis is caused by Burkholderia pseudomallei, a bacterium prevalent in Southeast Asia and Northern Australia.
  • Diagnosis is challenging due to varied symptoms and limitations of current identification methods.
  • High antimicrobial resistance leads to case fatality rates exceeding 70% with ineffective treatments.

Purpose of the Study:

  • To estimate the global burden of melioidosis.
  • To map the distribution of B. pseudomallei and melioidosis cases.
  • To identify underreported and potentially endemic regions.

Main Methods:

  • Documented human and animal cases were mapped.
  • Environmental presence of B. pseudomallei was recorded.
  • A formal modeling framework was used to estimate global disease burden.

Main Results:

  • An estimated 165,000 human melioidosis cases occur globally each year.
  • Approximately 89,000 deaths are attributed to melioidosis annually.
  • The disease is likely underreported in 45 endemic countries and potentially present in 34 additional countries.

Conclusions:

  • Melioidosis is a significant global health issue with a substantial estimated burden.
  • Current reporting significantly underestimates the true incidence and mortality.
  • Renewed attention from public health officials and policymakers is urgently needed.